Sector portfolio · VC firm · United States
GreatPoint Ventures' Biotech portfolio
GreatPoint Ventures has backed 12 Biotech startups in rounds we track, $984M between them, shown by the stage each has reached. The best-funded is Odyssey Therapeutics.
GreatPoint Ventures's whole portfolioGreatPoint Ventures's profile
Funding by segment
- Stage not reported$208M4
- Series C and later$566M4
- Pre-seed and seed$66M2
- Series B$144M2
Where they are based
- United States12$984M
United StatesFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M6
- $50M to $250M6
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
11 of 12 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States12
Startups by country, 1 country in all.
Segment by segment
Stage not reported
4 startups · $208M raised
Skyhawk TherapeuticsSkyhawk Therapeutics is a clinical-stage biotechnology company located in Waltham, Massachusetts.United States$133M
Glympse BioGlympse Bio is a biotechnology company that transforms disease detection and predict treatment response.United States$40M- SPSGX PharmaceuticalsSGX Pharmaceuticals is a biotechnology company that discovers, develops and markets therapeutics addressing medical needs in oncology.United States$25M
InsightRXInsightRX is a healthcare technology company that specializes in precision dosing through its cloud-based, AI-powered platform.United States$10M
Series C and later
4 startups · $566M raised
Odyssey TherapeuticsOdyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.United States$238M
Sidecar HealthSidecar Health, Inc.United States$183M
Truvian SciencesTruvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.United States$101M
OncoResponseOncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.United States$44M
Pre-seed and seed
2 startups · $66M raised
SkyhawkSkyhawk renders network monitoring, vendor management, virtualization, disaster recovery, video monitoring and asset tracking services.United States$48M
Current FoodsCurrent Foods creates plant-based alternatives for people's seafood favorites.United States$18M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names GreatPoint Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like GreatPoint Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.